ArticleJTO clinical and research reports2020

Oncogenic Fusions May Be Frequently Present at Resistance of EGFR Tyrosine Kinase Inhibitors in Patients With NSCLC: A Brief Report.

Diego Enrico et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.